Načítá se...
Switching and Escalating Therapy in Long-Lasting Multiple Sclerosis: Not Always Necessary
Although therapy switch is common among patients with multiple sclerosis (MS), sometimes the initial prescribed treatment is maintained for a long period with clinical stability, low disability, and nonsignificant side effects. We aim to describe demographic and clinical characteristics of patients...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Scholarly Research Network
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539327/ https://ncbi.nlm.nih.gov/pubmed/23316389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/451457 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|